Kisqali 600 MG daily dose UU 63S
Ended Awarded Last action
- Contract number
- SPE2DR26FV7Y0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,280
Award facts
- Contract value 100% obligated
- $12,280.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,280.00 to AmerisourceBergen Drug Corp for the supply of Kisqali 600 mg daily dose, a prescription medication commonly used in oncology treatments. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 11, 2026. The award was made to the prime contractor on January 21, 2026, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly known as AmerisourceBergen), a major pharmaceutical distributor providing critical medical supplies to federal government healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical, a global pharmaceutical prime vendor vehicle valued at up to $999,999,999.00 through December 2026. This IDC serves as the primary procurement vehicle for supplying a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including delivery to the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. The competitively awarded contract demonstrates AmerisourceBergen's established capability to efficiently fulfill essential pharmaceutical procurement requirements across multiple therapeutic domains for the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FV7Y0?
SPE2DR26FV7Y0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FV7Y0 worth?
The government has obligated $12,280 on SPE2DR26FV7Y0.
Is contract SPE2DR26FV7Y0 an order under another contract?
Yes. SPE2DR26FV7Y0 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7Y0 competed?
The extent of competition for SPE2DR26FV7Y0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award